2 results
8-K
EX-99.1
ANEB
Anebulo Pharmaceuticals Inc
13 Feb 24
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024
4:15pm
their on-going confidence and support as we continue to prepare for Phase 3 trials, a very important step in our mission.”
Financial Results for the three months
8-K
EX-99.1
ANEB
Anebulo Pharmaceuticals Inc
20 Sep 23
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2023
4:15pm
mission to make ANEB-001 available to individuals who present at emergency departments with cannabinoid intoxication,” commented Simon Allen, Chief
- Prev
- 1
- Next